Genetic studies are essential for the early and correct diagnosis of rare diseases.
#NARDS | The panel "Speeding Up Diagnostics with Innovative Solutions" has just started. This crucial discussion focuses on how cutting-edge approaches can revolutionize the diagnostic process for rare diseases, ultimately improving patient outcomes. Meet our esteemed panelists: 👉 Eric Klee, Associate Director for Research and Innovation, Center for Individualized Medicine, Mayo Clinic 👉Cheng-Kai Kao, Chief Medical Information Officer, University of Chicago Medicine 👉Krishna Tangella MD, MBA ✅, Full Clinical Professor of Pathology, University of Illinois & Medical Director of Laboratory, Sacred Heart Medical Center & CEO at DoveMed 👉Erin Conboy, MD, FACMG, Director, Undiagnosed Rare Disease Clinic at Indiana University School of Medicine 👉Tracy George, President, Innovation Business Unit & Chief Scientific Officer, ARUP Laboratories 👉 Joshua Wechsler, Medical Director, Eosinophilic Gastrointestinal Disorders Program, Lurie Children’s Hospital and a site-PI for Consortium of Eosinophilic Gastrointestinal Disease Researchers (CEGIR) Ultragenyx, Thrivewell Infusion, LLC, Novartis | Sanofi. #RareDiseases #HealthcareInnovation #OrphanDrugs #bamberghealth #RDSseries #rds #rareconditions #earlydiagnosis